So, if you can believe these dumbarse numnuts, the filings state
Cemp valued at 500 million
New Company 520 million
Cemp gets 48% New Company 52%
Without synergies this would put the stock at $9.00 valuation..
That is of course, if you believe the valuations..
As far as Cemp, the FDA break is a bit misleading. The trial size has been cut down but the intravenous indication has been removed. Oral is easier for approval, but intravenous would be from extremely sick patients in hospitals and would be a higher price point.
Oral would still be a second line antibiotic behind a generic.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM